Atrion develops and manufactures products, primarily for medical applications. Co. has developed various proprietary valves designed to fill, hold and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter and other applications in fields such as anesthesia and oncology. Co.'s primary cardiovascular products is the Myocardial Protection System, a proprietary technology that is used in open-heart surgery that delivers to the heart essential fluids and medications, mixes drugs and controls temperature, pressure and other variables. Co. also manufactures balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. We show 59 historical shares outstanding datapoints in our coverage of ATRI's shares outstanding history.
Understanding the changing numbers of ATRI shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ATRI versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ATRI by allowing them to research ATRI shares outstanding history
as well as any other stock in our coverage universe. |
Free ATRI Email Alerts:
Video: Shares Outstanding Importance
